• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与健康对照相比,炎症性肠病患者的粪便微生物群受肠道准备的影响较小:一项前瞻性研究的结果

The Fecal Microbiome of IBD Patients Is Less Divertible by Bowel Preparation Compared to Healthy Controls: Results From a Prospective Study.

作者信息

Blesl Andreas, Binder Lukas, Halwachs Bettina, Baumann-Durchschein Franziska, Fürst Stefan, Constantini-Kump Patrizia, Wenzl Heimo, Gorkiewicz Gregor, Högenauer Christoph

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Institute for Pharmaceutical Sciences, University of Graz, Graz, Austria.

出版信息

Inflamm Bowel Dis. 2025 Jul 7;31(7):2007-2018. doi: 10.1093/ibd/izaf053.

DOI:10.1093/ibd/izaf053
PMID:40296371
Abstract

BACKGROUND

The fecal microbiome of patients with inflammatory bowel diseases (IBD) is characterized by longitudinal variability. It remains unknown if this is caused by decreased resilience of the microbiome to external factors. We investigated the influence of osmotic diarrhea induced by bowel preparation as a disruptive factor on the fecal microbiome in IBD patients and healthy comparators.

METHODS

We conducted a prospective, single-center study including IBD patients and healthy controls scheduled for colonoscopy with uniform bowel preparation. Fecal samples were collected at 7 time points prior, during, and until 3 months after the intervention. 16S rRNA was isolated from stool and sequenced using the Illumina technique.

RESULTS

Twenty-two IBD patients and 17 healthy controls were included in the study. Baseline diversity was higher in healthy controls. Bowel preparation longitudinally decreased alpha diversity and altered beta diversity and taxonomic composition in both groups. Alterations were more pronounced in healthy controls, and the microbial composition converged between the 2 groups. Bowel preparation resulted in an increased relative abundance of Anaerostipes and Coprococcus in both groups and in decreased relative abundance of Bifidobacterium and Clostridium sensu stricto in IBD patients and of Eubacterium hallii group and Ruminococcus in healthy controls. Changes largely restored to baseline composition within 1 week in both groups and remained stable thereafter.

CONCLUSIONS

Bowel preparation induced reversible short-term microbial perturbations which were less pronounced in IBD patients than in healthy comparators suggesting that a single external disruptive factor may have less impact on an already altered fecal microbiome.

摘要

背景

炎症性肠病(IBD)患者的粪便微生物群具有纵向变异性。目前尚不清楚这是否是由于微生物群对外界因素的恢复力下降所致。我们研究了肠道准备引起的渗透性腹泻作为干扰因素对IBD患者和健康对照者粪便微生物群的影响。

方法

我们进行了一项前瞻性单中心研究,纳入计划进行结肠镜检查且肠道准备统一的IBD患者和健康对照者。在干预前、干预期间及干预后3个月内的7个时间点采集粪便样本。从粪便中分离16S rRNA,并使用Illumina技术进行测序。

结果

本研究纳入了22例IBD患者和17名健康对照者。健康对照者的基线多样性更高。肠道准备在纵向降低了两组的α多样性,改变了β多样性和分类组成。健康对照者的变化更为明显,两组之间的微生物组成趋于一致。肠道准备导致两组中厌氧棒状菌属和粪球菌属的相对丰度增加,IBD患者中双歧杆菌属和严格意义上的梭菌属以及健康对照者中土栖杆菌属组和瘤胃球菌属的相对丰度降低。两组的变化在1周内基本恢复到基线组成,此后保持稳定。

结论

肠道准备引起可逆的短期微生物扰动,IBD患者的扰动不如健康对照者明显,这表明单一的外部干扰因素可能对已经改变的粪便微生物群影响较小。

相似文献

1
The Fecal Microbiome of IBD Patients Is Less Divertible by Bowel Preparation Compared to Healthy Controls: Results From a Prospective Study.与健康对照相比,炎症性肠病患者的粪便微生物群受肠道准备的影响较小:一项前瞻性研究的结果
Inflamm Bowel Dis. 2025 Jul 7;31(7):2007-2018. doi: 10.1093/ibd/izaf053.
2
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
3
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
4
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.
5
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
6
Effects of a veterinary gastrointestinal diet on fecal characteristics, metabolites, and microbiota concentrations of adult cats treated with metronidazole.兽医肠胃饮食对接受甲硝唑治疗的成年猫的粪便特征、代谢物和微生物群落浓度的影响。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae274.
7
[1]The human gut microbiota in IBD, characterizing hubs, the core microbiota and terminal nodes: a network-based approach.[1]炎症性肠病中的人体肠道微生物群,表征枢纽、核心微生物群和终端节点:一种基于网络的方法。
BMC Microbiol. 2025 Jun 26;25(1):371. doi: 10.1186/s12866-025-04106-0.
8
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
9
[Changes of intestinal microflora in patients with colorectal benign and malignant tumors in high altitude area and comparison with the normal population in low altitude area].[高原地区结直肠良恶性肿瘤患者肠道菌群变化及与低海拔地区正常人群的比较]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):578-583. doi: 10.19723/j.issn.1671-167X.2025.03.023.
10
Alterations in vaginal microbiome in women with short cervix: longitudinal study of microbial diversity and impact of vaginal progesterone treatment.宫颈短的女性阴道微生物群的改变:微生物多样性的纵向研究及阴道孕酮治疗的影响
Ultrasound Obstet Gynecol. 2025 Jun 26. doi: 10.1002/uog.29269.

本文引用的文献

1
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations.粪便微生物负荷是肠道微生物组变异的主要决定因素,也是疾病关联研究中的一个混杂因素。
Cell. 2025 Jan 9;188(1):222-236.e15. doi: 10.1016/j.cell.2024.10.022. Epub 2024 Nov 13.
2
Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases.炎症性肠病中疾病适应细菌谱系的发现。
Cell Host Microbe. 2024 Jul 10;32(7):1147-1162.e12. doi: 10.1016/j.chom.2024.05.022. Epub 2024 Jun 24.
3
Ulcerative colitis.溃疡性结肠炎。
Lancet. 2023 Aug 12;402(10401):571-584. doi: 10.1016/S0140-6736(23)00966-2.
4
Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.肠道清洁对炎症性肠病患者和健康对照者肠道微生物群组成的影响。
Therap Adv Gastroenterol. 2023 Jun 6;16:17562848231174298. doi: 10.1177/17562848231174298. eCollection 2023.
5
Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.系统评价:肠道微生物群及其在炎症性肠病中的潜在临床应用
Microorganisms. 2021 Apr 30;9(5):977. doi: 10.3390/microorganisms9050977.
6
Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.炎症性肠病 (IBD) 与微生物组——在犯罪现场寻找线索。
Gastroenterology. 2021 Jan;160(2):524-537. doi: 10.1053/j.gastro.2020.09.056. Epub 2020 Nov 27.
7
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study.炎症性肠病中微生物组变异的排序:一项大型的纵向洲际研究。
Gut. 2021 Mar;70(3):499-510. doi: 10.1136/gutjnl-2020-321106. Epub 2020 Jun 14.
8
Gut microbiota, dysbiosis and colon lavage.肠道微生物群、失调和结肠灌洗。
Dig Liver Dis. 2019 Sep;51(9):1209-1213. doi: 10.1016/j.dld.2019.06.012. Epub 2019 Jul 27.
9
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.使用QIIME 2进行可重复、交互式、可扩展和可延伸的微生物组数据科学研究。
Nat Biotechnol. 2019 Aug;37(8):852-857. doi: 10.1038/s41587-019-0209-9.
10
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.炎症性肠病中的肠道微生物生态系统的多组学研究。
Nature. 2019 May;569(7758):655-662. doi: 10.1038/s41586-019-1237-9. Epub 2019 May 29.